182 related articles for article (PubMed ID: 35246806)
1. Gut microbiota metabolic characteristics in coronary artery disease patients with hyperhomocysteine.
Tian R; Liu HH; Feng SQ; Wang YF; Wang YY; Chen YX; Wang H; Zhang SY
J Microbiol; 2022 Apr; 60(4):419-428. PubMed ID: 35246806
[TBL] [Abstract][Full Text] [Related]
2. Alterations in the gut microbiome and metabolism with coronary artery disease severity.
Liu H; Chen X; Hu X; Niu H; Tian R; Wang H; Pang H; Jiang L; Qiu B; Chen X; Zhang Y; Ma Y; Tang S; Li H; Feng S; Zhang S; Zhang C
Microbiome; 2019 Apr; 7(1):68. PubMed ID: 31027508
[TBL] [Abstract][Full Text] [Related]
3. A red wine intervention does not modify plasma trimethylamine N-oxide but is associated with broad shifts in the plasma metabolome and gut microbiota composition.
Haas EA; Saad MJA; Santos A; Vitulo N; Lemos WJF; Martins AMA; Picossi CRC; Favarato D; Gaspar RS; Magro DO; Libby P; Laurindo FRM; Da Luz PL;
Am J Clin Nutr; 2022 Dec; 116(6):1515-1529. PubMed ID: 36205549
[TBL] [Abstract][Full Text] [Related]
4. [Gut microbiota and its metabolite trimethylamine-N-oxide (TMAO): a novel regulator in coronary artery disease].
Li Y; Cui M; Sun J; Wei Q; Liu M; Zhang J; Qi H; Zhao L; Fang H; Chen Z; Lü S
Sheng Wu Gong Cheng Xue Bao; 2021 Nov; 37(11):3745-3756. PubMed ID: 34841781
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota combined with metabolites reveals unique features of acute myocardial infarction patients different from stable coronary artery disease.
Dong C; Yang Y; Wang Y; Hu X; Wang Q; Gao F; Sun S; Liu Q; Li L; Liu J; Tang Y; Zhang S; Wu C; Zhu H
J Adv Res; 2023 Apr; 46():101-112. PubMed ID: 35750287
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota-derived metabolites and risk of coronary artery disease: a prospective study among US men and women.
Liu G; Li J; Li Y; Hu Y; Franke AA; Liang L; Hu FB; Chan AT; Mukamal KJ; Rimm EB; Sun Q
Am J Clin Nutr; 2021 Jul; 114(1):238-247. PubMed ID: 33829245
[TBL] [Abstract][Full Text] [Related]
7. The gut microbiota-related metabolite phenylacetylglutamine associates with increased risk of incident coronary artery disease.
Ottosson F; Brunkwall L; Smith E; Orho-Melander M; Nilsson PM; Fernandez C; Melander O
J Hypertens; 2020 Dec; 38(12):2427-2434. PubMed ID: 32665522
[TBL] [Abstract][Full Text] [Related]
8. Dysbiosis signatures of gut microbiota in coronary artery disease.
Zhu Q; Gao R; Zhang Y; Pan D; Zhu Y; Zhang X; Yang R; Jiang R; Xu Y; Qin H
Physiol Genomics; 2018 Oct; 50(10):893-903. PubMed ID: 30192713
[TBL] [Abstract][Full Text] [Related]
9. Gut Microbiota Alterations and Circulating Imidazole Propionate Levels Are Associated With Obstructive Coronary Artery Disease in People With HIV.
Trøseid M; Molinaro A; Gelpi M; Vestad B; Kofoed KF; Fuchs A; Køber L; Holm K; Benfield T; Ueland PM; Hov JR; Nielsen SD; Knudsen AD
J Infect Dis; 2024 Mar; 229(3):898-907. PubMed ID: 38195204
[TBL] [Abstract][Full Text] [Related]
10. The Effects of Moderate Alcohol Consumption on Circulating Metabolites and Gut Microbiota in Patients With Coronary Artery Disease.
Zhao X; Zhou R; Li H; Fan Y; Sun Y; Hu X; Zhang S
Front Cardiovasc Med; 2021; 8():767692. PubMed ID: 34796220
[No Abstract] [Full Text] [Related]
11. Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease.
Yoshida N; Sasaki K; Sasaki D; Yamashita T; Fukuda H; Hayashi T; Tabata T; Osawa R; Hirata KI; Kondo A
J Atheroscler Thromb; 2019 Aug; 26(8):705-719. PubMed ID: 30587666
[TBL] [Abstract][Full Text] [Related]
12. The Role of Gut Microbiota and Trimethylamine N-oxide in Cardiovascular Diseases.
Huang Y; Zhang H; Fan X; Wang J; Yin Y; Zhang Y; Shi K; Yu F
J Cardiovasc Transl Res; 2023 Jun; 16(3):581-589. PubMed ID: 36251229
[TBL] [Abstract][Full Text] [Related]
13. Alterations in Gut Microbiota Are Correlated With Serum Metabolites in Patients With Insomnia Disorder.
Zhou J; Wu X; Li Z; Zou Z; Dou S; Li G; Yan F; Chen B; Li Y
Front Cell Infect Microbiol; 2022; 12():722662. PubMed ID: 35252021
[TBL] [Abstract][Full Text] [Related]
14. Gut Microbiome-Based Diagnostic Model to Predict Coronary Artery Disease.
Zheng YY; Wu TT; Liu ZQ; Li A; Guo QQ; Ma YY; Zhang ZL; Xun YL; Zhang JC; Wang WR; Kadir P; Wang DY; Ma YT; Zhang JY; Xie X
J Agric Food Chem; 2020 Mar; 68(11):3548-3557. PubMed ID: 32100534
[TBL] [Abstract][Full Text] [Related]
15. Combined effect of hyperhomocysteinemia and smoking on the severity of coronary artery disease in young adults ≤ 35 years of age: a hospital-based observational study.
Sun J; Han W; Wu S; Jia S; Yan Z; Guo Y; Zhao Y; Zhou Y; Liu X
BMC Cardiovasc Disord; 2021 Oct; 21(1):484. PubMed ID: 34627150
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbiota and Environment in Coronary Artery Disease.
Piccioni A; de Cunzo T; Valletta F; Covino M; Rinninella E; Raoul P; Zanza C; Mele MC; Franceschi F
Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33923612
[TBL] [Abstract][Full Text] [Related]
17. [Impact of L-carnitine and phosphatidylcholine containing products on the proatherogenic metabolite TMAO production and gut microbiome changes in patients with coronary artery disease].
Ivashkin VT; Kashukh YA
Vopr Pitan; 2019; 88(4):25-33. PubMed ID: 31722138
[No Abstract] [Full Text] [Related]
18. [Distribution characteristics of trimethylamine N-oxide and its association with gut microbiota].
Wang S; Xia GH; He Y; Liao SX; Yin J; Sheng HF; Zhou HW
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 36(4):455-60. PubMed ID: 27113169
[TBL] [Abstract][Full Text] [Related]
19. Integrated 16S rRNA Gene Sequencing and LC-MS Analysis Revealed the Interplay Between Gut Microbiota and Plasma Metabolites in Rats With Ischemic Stroke.
Wu W; Sun Y; Luo N; Cheng C; Jiang C; Yu Q; Cheng S; Ge J
J Mol Neurosci; 2021 Oct; 71(10):2095-2106. PubMed ID: 33954858
[TBL] [Abstract][Full Text] [Related]
20. Role of Gut Microbiota on Cardio-Metabolic Parameters and Immunity in Coronary Artery Disease Patients with and without Type-2 Diabetes Mellitus.
Sanchez-Alcoholado L; Castellano-Castillo D; Jordán-Martínez L; Moreno-Indias I; Cardila-Cruz P; Elena D; Muñoz-Garcia AJ; Queipo-Ortuño MI; Jimenez-Navarro M
Front Microbiol; 2017; 8():1936. PubMed ID: 29051757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
